AWA
ONC

Acumen Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Acumen Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.56K Hold
16
– – ﹤0.01% 408
2026
Q1 		$4.75K Buy
16
+1
+7% +$324 ﹤0.01% 388
2025
Q4 		$4.56K Buy
+15
New +$4.91K ﹤0.01% 387

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Acumen Wealth Advisors's ONC Position: Q2 2026 in Review

Acumen Wealth Advisors held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 16 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Acumen Wealth Advisors first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.75K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Acumen Wealth Advisors held 16 shares of BeOne Medicines Ltd worth $4.56K as of Q2 2026.
  • Acumen Wealth Advisors left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Acumen Wealth Advisors's portfolio in Q2 2026, its #408 holding.
  • Acumen Wealth Advisors first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • Acumen Wealth Advisors's BeOne Medicines Ltd position peaked at $4.75K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Acumen Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.